Study S000175

Effect of Exenatide on Cortisol Secretion

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03160261
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 10
Start: 2017-09-07
Primary completion: 2017-12-28
Lead sponsor: University of Tartu
Conditions: Healthy
Interventions: DRUG:Exenatide Injection
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Cortisol peak [every 30 minutes during 2 hours after injection]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0004869	GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers. Heinla K, Diabetes therapy : research, treatment and education of diabetes and related disorders	2023	Randomized trial	PMID 36800161 DOI	cites ClinicalTrials.gov:NCT03160261; registry reference DERIVED:36800161